Catalyst Pharmaceuticals
Manufacturing · Florida, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
355 Alhambra Cir Ste 801, Coral Gables, ...Phone Number
(305) 420-3200Website
www.catalystpharma.comRevenue
$597 MillionStock Symbol
CPRXIndustry
About Catalyst Pharmaceuticals
Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company founded in 2002 that develops and markets therapies for patients with rare and difficult-to-treat neurological and epileptic diseases. Its portfolio includes treatments for Lambert-Eaton myasthenic syndrome (LEMS), Duchenne muscular dystrophy-associated cardiomyopathy, and other rare disorders. The company focuses on acquiring, developing, and commercializing innovative medicines that address significant unmet medical needs.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: CPRXShow moreCatalyst Pharmaceuticals Org Chart
Compare Similar Companies to Catalyst Pharmaceuticals
Compare insights from companies similar to Catalyst Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Catalyst Pharmaceuticals Tech Stack
A closer look at the technologies used by Catalyst Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Catalyst Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company founded in 2002 that develops and markets therapies for patients with rare and difficult-to-treat neurological and epileptic diseases. Its portfolio includes treatments for Lambert-Eaton myasthenic syndrome (LEMS), Duchenne muscular dystrophy-associated cardiomyopathy, and oth... Read More


